AIS1
MCID: ATM052
MIFTS: 37

Autoimmune Disease 1 (AIS1)

Categories: Genetic diseases

Aliases & Classifications for Autoimmune Disease 1

MalaCards integrated aliases for Autoimmune Disease 1:

Name: Autoimmune Disease 1 56 73 29 6
Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2 56 73
Autoimmune Disease, Susceptibility to, 1 56 13
Autoimmune Diseases 43 71
Vamas2 56 73
Ais1 56 73
Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2; Vamas2 56
Autoimmune Disease Susceptibility Locus, Chromosome 1p-Related 56
Autoimmune Disease Susceptibility Locus Chromosome 1p-Related 73
Vitiligo-Associated Multiple Autoimmune Disease Type 2 73
Autoimmune Disease, Susceptibility to, Type 1 39
Autoimmune Disease Susceptibility 1 73

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant

Miscellaneous:
early age at onset (13 years)


HPO:

31
autoimmune disease 1:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 56 607836
MeSH 43 D001327
MedGen 41 C1842979
SNOMED-CT via HPO 68 21983002 263681008 56727007
UMLS 71 C0004364

Summaries for Autoimmune Disease 1

UniProtKB/Swiss-Prot : 73 Autoimmune disease 1: An autoimmune disorder characterized by the association of vitiligo with autoimmune thyroiditis (Hashimoto thyroiditis).

MalaCards based summary : Autoimmune Disease 1, also known as vitiligo-associated multiple autoimmune disease susceptibility 2, is related to autoimmune disease 6 and autoimmune disease, multisystem, with facial dysmorphism. An important gene associated with Autoimmune Disease 1 is FOXD3 (Forkhead Box D3). The drugs Ledipasvir and Sofosbuvir have been mentioned in the context of this disorder. Affiliated tissues include thyroid, t cells and bone, and related phenotypes are hashimoto thyroiditis and vitiligo

More information from OMIM: 607836

Related Diseases for Autoimmune Disease 1

Diseases related to Autoimmune Disease 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1311, show less)
# Related Disease Score Top Affiliating Genes
1 autoimmune disease 6 12.6
2 autoimmune disease, multisystem, with facial dysmorphism 12.5
3 autoimmune disease, multisystem, infantile-onset, 1 12.5
4 autoimmune disease, multisystem, infantile-onset, 2 12.4
5 autoimmune disease 4 12.4
6 autoimmune disease of peripheral nervous system 12.3
7 systemic autoimmune disease 12.3
8 autoimmune disease of central nervous system 12.1
9 autoimmune disease of endocrine system 12.1
10 autoimmune disease of exocrine system 12.1
11 autoimmune disease of eyes, ear, nose and throat 12.1
12 autoimmune disease of gastrointestinal tract 12.1
13 autoimmune disease of musculoskeletal system 12.1
14 autoimmune disease of skin and connective tissue 12.1
15 autoimmune disease of urogenital tract 12.1
16 autoimmune disease of blood 12.1
17 autoimmune disease of cardiovascular system 12.1
18 secondary neonatal autoimmune disease 12.1
19 sjogren's syndrome, juvenile, secondary to autoimmune disease 12.1
20 inflammatory and autoimmune disease with epilepsy 12.1
21 autoimmune disease with skin involvement 12.1
22 postinfectious autoimmune disease with chorea 12.1
23 vitiligo-associated multiple autoimmune disease susceptibility 1 11.7
24 itch e3 ubiquitin ligase deficiency 11.7
25 sjogren syndrome 11.6
26 celiac disease 6 11.5
27 graves' disease 11.5
28 celiac disease 1 11.5
29 pemphigus 11.5
30 rheumatoid arthritis 11.5
31 mixed connective tissue disease 11.5
32 myasthenia gravis 11.5
33 primary biliary cirrhosis 11.4
34 undifferentiated connective tissue disease 11.4
35 stiff-person syndrome 11.4
36 goodpasture syndrome 11.4
37 scleroderma, familial progressive 11.4
38 multiple sclerosis 11.4
39 autoimmune hepatitis 11.4
40 igg4-related disease 11.4
41 neuromyelitis optica 11.4
42 interstitial lung disease 11.4
43 microscopic polyangiitis 11.4
44 lambert-eaton myasthenic syndrome 11.3
45 vogt-koyanagi-harada disease 11.3
46 cold agglutinin disease 11.3
47 dermatomyositis 11.3
48 premature ovarian failure 1 11.3
49 polymyositis 11.3
50 juvenile rheumatoid arthritis 11.3
51 diabetes mellitus, type i 11.3
52 psoriasis 11.3
53 bullous pemphigoid 11.3
54 anemia, autoimmune hemolytic 11.3
55 alopecia areata 11.3
56 myositis 11.3
57 pemphigus vulgaris, familial 11.3
58 guillain-barre syndrome 11.3
59 granulomatosis with polyangiitis 11.3
60 autoimmune gastritis 11.3
61 autoimmune uveitis 11.3
62 diabetes mellitus 11.3
63 aplastic anemia 11.3
64 immune deficiency disease 11.3
65 exanthem 11.3
66 autoimmune pancreatitis 11.2
67 common variable immunodeficiency 11.2
68 autoimmune encephalitis 11.2
69 cutaneous lupus erythematosus 11.2
70 chronic inflammatory demyelinating polyradiculoneuropathy 11.2
71 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.2
72 heart block, congenital 11.2
73 membranous nephropathy 11.2
74 hypoparathyroidism 11.2
75 adult-onset still's disease 11.2
76 optic neuritis 11.2
77 acquired hemophilia 11.2
78 autoimmune oophoritis 11.2
79 autoimmune glomerulonephritis 11.2
80 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 11.2
81 autoimmune myocarditis 11.2
82 behcet syndrome 11.2
83 immunoglobulin a deficiency 1 11.2
84 autoimmune polyendocrine syndrome 11.2
85 cogan syndrome 11.2
86 pure red-cell aplasia 11.2
87 evans' syndrome 11.2
88 membranoproliferative glomerulonephritis 11.2
89 c1q deficiency 11.2
90 autoimmune vasculitis 11.2
91 cicatricial pemphigoid 11.2
92 distal renal tubular acidosis 11.2
93 felty syndrome 11.2
94 eosinophilic fasciitis 11.2
95 neuromuscular disease 11.2
96 reactive arthritis 11.2
97 reynolds syndrome 11.2
98 pemphigus gestationis 11.2
99 hirata disease 11.2
100 aicardi-goutieres syndrome 11.2
101 acute disseminated encephalomyelitis 11.2
102 acquired hemophilia a 11.2
103 alopecia areata 1 11.2
104 complement component 2 deficiency 11.2
105 autoimmune cardiomyopathy 11.2
106 autoimmune atherosclerosis 11.2
107 miller fisher syndrome 11.2
108 capillary leak syndrome 11.2
109 sclerosing keratitis 11.2
110 bullous skin disease 11.2
111 autoimmune polyglandular syndrome type 3 11.2
112 insulin-resistance type b 11.1
113 aicardi-goutieres syndrome 1 11.1
114 sneddon syndrome 11.0
115 spondyloenchondrodysplasia with immune dysregulation 11.0
116 immunodeficiency 17 11.0
117 yellow nail syndrome 10.9
118 iga nephropathy 1 10.9
119 bronchiectasis with or without elevated sweat chloride 1 10.9
120 buerger disease 10.9
121 pseudo-torch syndrome 1 10.9
122 tn polyagglutination syndrome 10.9
123 satoyoshi syndrome 10.9
124 birdshot chorioretinopathy 10.9
125 lipodystrophy, partial, acquired 10.9
126 bronchiectasis with or without elevated sweat chloride 2 10.9
127 bronchiectasis with or without elevated sweat chloride 3 10.9
128 complement component 3 deficiency, autosomal recessive 10.9
129 masp2 deficiency 10.9
130 familial cold autoinflammatory syndrome 3 10.9
131 facial dysmorphism, immunodeficiency, livedo, and short stature 10.9
132 immunodeficiency 14 10.9
133 melioidosis 10.9
134 autoimmune interstitial lung, joint, and kidney disease 10.9
135 yao syndrome 10.9
136 immunodeficiency 52 10.9
137 autoimmune peripheral neuropathy 10.9
138 autoimmune optic neuritis 10.9
139 juvenile ankylosing spondylitis 10.9
140 selective igm deficiency disease 10.9
141 immunoglobulin beta deficiency 10.9
142 autoimmune neuropathy 10.9
143 acquired generalized lipodystrophy 10.9
144 sting-associated vasculopathy with onset in infancy 10.9
145 palindromic rheumatism 10.9
146 episcleritis periodica fugax 10.9
147 scleroperikeratitis 10.9
148 scleromalacia perforans 10.9
149 brawny scleritis 10.9
150 reye syndrome 10.9
151 gastric antral vascular ectasia 10.9
152 immune system disease 10.9
153 spinal cord disease 10.9
154 complement component 3 deficiency 10.9
155 subcorneal pustular dermatosis 10.9
156 erythromelalgia 10.9
157 acquired angioedema 10.9
158 antisynthetase syndrome 10.9
159 autoimmune gastrointestinal dysmotility 10.9
160 autoimmune retinopathy 10.9
161 collagenous gastritis 10.9
162 enthesitis-related juvenile idiopathic arthritis 10.9
163 fibrillary glomerulonephritis 10.9
164 ichthyosis, acquired 10.9
165 idiopathic hypertrophic pachymeningitis 10.9
166 immunotactoid glomerulopathy 10.9
167 immunotactoid or fibrillary glomerulopathy 10.9
168 localized lipodystrophy 10.9
169 pseudopelade of brocq 10.9
170 psoriatic juvenile idiopathic arthritis 10.9
171 punctate inner choroidopathy 10.9
172 vasculitis 10.7
173 glomerulonephritis 10.6
174 connective tissue disease 10.6
175 inflammatory bowel disease 10.6
176 systemic scleroderma 10.6
177 antiphospholipid syndrome 10.6
178 purpura 10.5
179 inflammatory spondylopathy 10.5
180 spondylitis 10.5
181 spondyloarthropathy 1 10.5
182 crohn's disease 10.5
183 hemolytic anemia 10.5
184 juvenile arthritis 10.4
185 sarcoidosis 1 10.4
186 gastritis 10.4
187 ulcerative colitis 10.4
188 alopecia 10.4
189 pustulosis of palm and sole 10.4
190 psoriatic arthritis 10.4
191 graft-versus-host disease 10.4
192 cytokine deficiency 10.4
193 pernicious anemia 10.4
194 hyperthyroidism 10.4
195 lymphoma 10.4
196 skin disease 10.3
197 myocarditis 10.3
198 thrombocytopenia 10.3
199 splenomegaly 10.3
200 thrombocytopenic purpura, autoimmune 10.3
201 cholangitis 10.3
202 vitiligo-associated multiple autoimmune disease susceptibility 6 10.3
203 dermatitis, atopic 10.3
204 arthritis 10.3
205 polyarteritis nodosa 10.3
206 sclerosing cholangitis 10.3
207 vascular disease 10.3
208 cryoglobulinemia 10.3
209 lung disease 10.3
210 temporal arteritis 10.3
211 liver cirrhosis 10.3
212 atherosclerosis susceptibility 10.3
213 myopathy 10.3
214 polyendocrinopathy 10.3
215 demyelinating disease 10.2
216 raynaud phenomenon 10.2
217 cholangitis, primary sclerosing 10.2
218 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 10.2
219 neutropenia 10.2
220 b-cell lymphoma 10.2
221 anca-associated vasculitis 10.2
222 liver disease 10.2
223 lymphoproliferative syndrome 10.2
224 urticaria 10.2
225 neuritis 10.2
226 lymphoma, hodgkin, classic 10.2
227 candidiasis 10.2
228 thymoma, familial 10.2
229 rickets 10.2
230 leukemia 10.2
231 rheumatic fever 10.2
232 thrombocytopenia due to platelet alloimmunization 10.2
233 orchitis 10.2
234 thymoma 10.2
235 lymphopenia 10.2
236 severe combined immunodeficiency 10.2
237 leukemia, chronic lymphocytic 10.2
238 bacterial infectious disease 10.2
239 polyneuropathy 10.2
240 fibromyalgia 10.2
241 encephalitis 10.2
242 crohn's colitis 10.2
243 relapsing-remitting multiple sclerosis 10.2
244 collagen disease 10.2
245 sialadenitis 10.2
246 allergic hypersensitivity disease 10.2
247 dilated cardiomyopathy 10.2
248 enthesopathy 10.2
249 dermatitis herpetiformis, familial 10.1
250 dermatitis 10.1
251 dermatitis herpetiformis 10.1
252 chronic graft versus host disease 10.1
253 hashimoto thyroiditis 10.1
254 autoimmune disease 2 10.1
255 autoimmune disease 3 10.1
256 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
257 hypoadrenocorticism, familial 10.1
258 proteasome-associated autoinflammatory syndrome 1 10.1
259 lymphoma, non-hodgkin, familial 10.1
260 relapsing polychondritis 10.1
261 kawasaki disease 10.1
262 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
263 immunoglobulin alpha deficiency 10.1
264 goiter 10.1
265 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.1
266 deficiency anemia 10.1
267 pulmonary hypertension 10.1
268 pre-eclampsia 10.1
269 hepatitis c 10.1
270 pulmonary fibrosis 10.1
271 immune-complex glomerulonephritis 10.1
272 demyelinating polyneuropathy 10.1
273 lichen planus 10.1
274 homologous wasting disease 10.1
275 osteoporosis 10.1
276 hepatitis c virus 10.1
277 hyperprolactinemia 10.1
278 eye disease 10.1
279 graves disease 1 10.1
280 autoimmune lymphoproliferative syndrome 10.1
281 bone mineral density quantitative trait locus 8 10.1
282 bone mineral density quantitative trait locus 15 10.1
283 diffuse large b-cell lymphoma 10.1
284 endometriosis 10.1
285 churg-strauss syndrome 10.1
286 herpes zoster 10.1
287 autoimmune disease 10.1
288 ige responsiveness, atopic 10.1
289 autism 10.1
290 sensorineural hearing loss 10.1
291 pertussis 10.1
292 rhinitis 10.1
293 lymphoma, mucosa-associated lymphoid type 10.0
294 keratitis, hereditary 10.0
295 thrombophilia due to thrombin defect 10.0
296 myelodysplastic syndrome 10.0
297 chorea, childhood-onset, with psychomotor retardation 10.0
298 choreatic disease 10.0
299 gout 10.0
300 myeloid leukemia 10.0
301 narcolepsy 10.0
302 iridocyclitis 10.0
303 acute graft versus host disease 10.0
304 cryoglobulinemia, familial mixed 10.0
305 myeloma, multiple 10.0
306 allergic rhinitis 10.0
307 autism spectrum disorder 10.0
308 colitis 10.0
309 covid-19 10.0
310 ovarian disease 10.0
311 lymphocytic choriomeningitis 10.0
312 keratoconjunctivitis sicca 10.0
313 childhood type dermatomyositis 10.0
314 agammaglobulinemia 10.0
315 epidermolysis bullosa 10.0
316 arthropathy 10.0
317 pneumonia 10.0
318 atrophic gastritis 10.0
319 macrophage activation syndrome 10.0
320 discoid lupus erythematosus 10.0
321 thyroid carcinoma 10.0
322 amyotrophic lateral sclerosis 1 10.0
323 pulmonary hypertension, primary, 1 10.0
324 takayasu arteritis 10.0
325 ataxia and polyneuropathy, adult-onset 10.0
326 helicobacter pylori infection 10.0
327 crest syndrome 10.0
328 thrombotic thrombocytopenic purpura 10.0
329 pancytopenia 10.0
330 eclampsia 10.0
331 cystitis 10.0
332 lateral sclerosis 10.0
333 iga glomerulonephritis 10.0
334 epidermolysis bullosa acquisita 10.0
335 proliferative glomerulonephritis 10.0
336 pancreatitis 10.0
337 sleep disorder 10.0
338 measles 10.0
339 neuropathy 10.0
340 allergic angiitis 10.0
341 multifocal motor neuropathy 10.0
342 pemphigus foliaceus 10.0
343 atrial standstill 1 10.0
344 ocular cicatricial pemphigoid 10.0
345 leukemia, acute myeloid 10.0
346 marginal zone b-cell lymphoma 10.0
347 thrombosis 10.0
348 silicosis 10.0
349 respiratory failure 10.0
350 pneumocystosis 10.0
351 nephrotic syndrome 10.0
352 hepatitis 10.0
353 end stage renal disease 10.0
354 localized scleroderma 10.0
355 chickenpox 10.0
356 hemophilia 10.0
357 pik3ca-related overgrowth syndrome 10.0
358 neurofibromatosis, type ii 9.9
359 pfeiffer syndrome 9.9
360 glucocorticoid-induced osteoporosis 9.9
361 henoch-schoenlein purpura 9.9
362 prostatitis 9.9
363 cholera 9.9
364 acute kidney failure 9.9
365 turner syndrome 9.9
366 infertility 9.9
367 gastrointestinal system disease 9.9
368 amyloidosis 9.9
369 keratoconjunctivitis 9.9
370 hypereosinophilic syndrome 9.9
371 oral lichen planus 9.9
372 hand skill, relative 9.9
373 obsessive-compulsive disorder 9.9
374 schizophrenia 9.9
375 aging 9.9
376 systemic lupus erythematosus 1 9.9
377 pulmonary disease, chronic obstructive 9.9
378 rheumatic heart disease 9.9
379 follicular lymphoma 9.9
380 cutaneous t cell lymphoma 9.9
381 interstitial nephritis 9.9
382 pulmonary alveolar proteinosis 9.9
383 chagas disease 9.9
384 plica syndrome 9.9
385 hepatitis a 9.9
386 interstitial cystitis 9.9
387 gonadal dysgenesis 9.9
388 calcinosis 9.9
389 chronic mucocutaneous candidiasis 9.9
390 synovitis 9.9
391 myelitis 9.9
392 peripheral nervous system disease 9.9
393 acquired immunodeficiency syndrome 9.9
394 periodontitis 9.9
395 herpes simplex 9.9
396 pulmonary embolism 9.9
397 dacryoadenitis 9.9
398 lymphomatous thyroiditis 9.9
399 depression 9.9
400 cytomegalovirus infection 9.9
401 subacute cutaneous lupus erythematosus 9.9
402 toxic oil syndrome 9.9
403 red cell aplasia 9.9
404 alzheimer disease 9.9
405 hepatocellular carcinoma 9.9
406 attention deficit-hyperactivity disorder 9.9
407 hypercholesterolemia, familial, 1 9.9
408 lichen sclerosus et atrophicus 9.9
409 migraine with or without aura 1 9.9
410 raynaud disease 9.9
411 triiodothyronine receptor auxiliary protein 9.9
412 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
413 myxedema 9.9
414 branchiootic syndrome 1 9.9
415 systemic lupus erythematosus 3 9.9
416 major affective disorder 8 9.9
417 major affective disorder 9 9.9
418 melanoma, cutaneous malignant 10 9.9
419 hemophagocytic lymphohistiocytosis 9.9
420 atrioventricular block 9.9
421 sleep apnea 9.9
422 interleukin-7 receptor alpha deficiency 9.9
423 hypogonadotropic hypogonadism 9.9
424 osteonecrosis 9.9
425 brucellosis 9.9
426 spondyloarthropathy 9.9
427 chlamydia 9.9
428 tetanus 9.9
429 hemopericardium 9.9
430 pericardial effusion 9.9
431 sympathetic ophthalmia 9.9
432 hemolytic-uremic syndrome 9.9
433 telangiectasis 9.9
434 crescentic glomerulonephritis 9.9
435 acute cystitis 9.9
436 scleritis 9.9
437 cholestasis 9.9
438 toxic shock syndrome 9.9
439 renal tubular acidosis 9.9
440 angioedema 9.9
441 pericarditis 9.9
442 epilepsy 9.9
443 viral hepatitis 9.9
444 melanoma 9.9
445 hepatitis b 9.9
446 polyclonal hypergammaglobulinemia 9.9
447 thrombophilia 9.9
448 psychotic disorder 9.9
449 tic disorder 9.9
450 severe acute respiratory syndrome 9.9
451 food allergy 9.9
452 lipid metabolism disorder 9.9
453 chronic granulomatous disease 9.9
454 vaccinia 9.9
455 bipolar disorder 9.9
456 syphilis 9.9
457 peptic ulcer disease 9.9
458 allergic asthma 9.9
459 hypoglycemia 9.9
460 47,xyy 9.9
461 autoimmune enteropathy 9.9
462 glioma 9.9
463 systemic onset juvenile idiopathic arthritis 9.9
464 autonomic dysfunction 9.9
465 encephalopathy 9.9
466 rapidly involuting congenital hemangioma 9.9
467 paraneoplastic pemphigus 9.9
468 severe immune-mediated enteropathy 9.9
469 systemic lupus erythematosus 9.8
470 hypertriglyceridemia, familial 9.8
471 leprosy 3 9.8
472 moyamoya disease 1 9.8
473 asthma 9.8
474 yemenite deaf-blind hypopigmentation syndrome 9.8
475 leukemia, chronic myeloid 9.8
476 human immunodeficiency virus type 1 9.8
477 multiple sclerosis 2 9.8
478 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.8
479 autoimmune polyendocrine syndrome type 1 9.8
480 erythema multiforme 9.8
481 autosomal recessive disease 9.8
482 nodal marginal zone lymphoma 9.8
483 pleurisy 9.8
484 parotitis 9.8
485 mastitis 9.8
486 portal hypertension 9.8
487 polycystic ovary syndrome 9.8
488 acute leukemia 9.8
489 dementia 9.8
490 amenorrhea 9.8
491 hereditary angioedema 9.8
492 alcohol use disorder 9.8
493 hypogonadism 9.8
494 constipation 9.8
495 papilloma 9.8
496 bronchiolitis 9.8
497 inner ear disease 9.8
498 mood disorder 9.8
499 skin carcinoma 9.8
500 aortic aneurysm 9.8
501 hyperglycemia 9.8
502 polyradiculoneuropathy 9.8
503 movement disease 9.8
504 dystonia 9.8
505 congestive heart failure 9.8
506 adenoma 9.8
507 t-cell lymphoblastic leukemia/lymphoma 9.8
508 peritonitis 9.8
509 cataract 9.8
510 chronic fatigue syndrome 9.8
511 rubella 9.8
512 macroglobulinemia 9.8
513 hypopituitarism 9.8
514 irritable bowel syndrome 9.8
515 hypersensitivity vasculitis 9.8
516 autoimmune atrophic gastritis 9.8
517 hansen's disease 9.8
518 heparin-induced thrombocytopenia 9.8
519 leukemia, t-cell, chronic 9.8
520 limbic encephalitis 9.8
521 nodular regenerative hyperplasia 9.8
522 stevens-johnson syndrome/toxic epidermal necrolysis 9.8
523 transverse myelitis 9.8
524 dysphagia 9.8
525 myoclonus 9.8
526 glial tumor 9.8
527 neonatal lupus erythematosus 9.8
528 diffuse alveolar hemorrhage 9.8
529 aortic aneurysm, familial abdominal, 1 9.8
530 esophageal cancer 9.8
531 hypertension, essential 9.8
532 inclusion body myositis 9.8
533 parkinson disease, late-onset 9.8
534 psoriasis 1 9.8
535 pulmonary fibrosis, idiopathic 9.8
536 dowling-degos disease 1 9.8
537 alopecia universalis congenita 9.8
538 chondrodysplasia punctata syndrome 9.8
539 hemolytic uremic syndrome, atypical 1 9.8
540 familial mediterranean fever 9.8
541 wiskott-aldrich syndrome 9.8
542 hemophilia a 9.8
543 frontotemporal dementia 9.8
544 cervical cancer 9.8
545 cataract 26, multiple types 9.8
546 anorexia nervosa 9.8
547 bulimia nervosa 9.8
548 kala-azar 1 9.8
549 systemic lupus erythematosus 4 9.8
550 chilblain lupus 1 9.8
551 gastric cancer 9.8
552 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.8
553 leukemia, acute lymphoblastic 3 9.8
554 helix syndrome 9.8
555 female breast cancer 9.8
556 vitamin b12 deficiency 9.8
557 secondary progressive multiple sclerosis 9.8
558 aphasia 9.8
559 collagenous colitis 9.8
560 bone disease 9.8
561 bone resorption disease 9.8
562 xerophthalmia 9.8
563 neuroretinitis 9.8
564 endocarditis 9.8
565 t cell deficiency 9.8
566 heart disease 9.8
567 diphtheria 9.8
568 autonomic neuropathy 9.8
569 aseptic meningitis 9.8
570 nodular goiter 9.8
571 diarrhea 9.8
572 squamous cell papilloma 9.8
573 pemphigoid gestationis 9.8
574 labyrinthitis 9.8
575 hypersensitivity reaction type iii disease 9.8
576 hyperuricemia 9.8
577 arteriosclerosis 9.8
578 iron metabolism disease 9.8
579 kidney cancer 9.8
580 bronchiolitis obliterans 9.8
581 euthyroid sick syndrome 9.8
582 acute pancreatitis 9.8
583 cellulitis 9.8
584 retinitis 9.8
585 acute myocarditis 9.8
586 aortitis 9.8
587 conjunctivitis 9.8
588 complement deficiency 9.8
589 progressive multifocal leukoencephalopathy 9.8
590 cerebrovascular disease 9.8
591 monoclonal gammopathy of uncertain significance 9.8
592 chronic kidney disease 9.8
593 nervous system disease 9.8
594 eating disorder 9.8
595 erythema infectiosum 9.8
596 rosacea 9.8
597 leishmaniasis 9.8
598 achalasia 9.8
599 exophthalmos 9.8
600 fasciitis 9.8
601 stomatitis 9.8
602 al amyloidosis 9.8
603 chromosomal triplication 9.8
604 persistent genital arousal disorder 9.8
605 scleromyxedema 9.8
606 aneurysm 9.8
607 dysautonomia 9.8
608 headache 9.8
609 tremor 9.8
610 b-cell non-hodgkin lymphoma 9.8
611 granulomatous mastitis 9.8
612 autoimmune hepatitis type 1 9.8
613 autoinflammatory syndrome 9.8
614 uveitis 9.7
615 hypothyroidism 9.7
616 thyroid gland disease 9.7
617 thyroiditis 9.7
618 lupus erythematosus 9.7
619 allergic encephalomyelitis 9.7
620 burkitt lymphoma 9.7
621 colorectal cancer 9.7
622 seizures, benign familial neonatal, 1 9.7
623 periodic fever, familial, autosomal dominant 9.7
624 renal cell carcinoma, nonpapillary 9.7
625 kaposi sarcoma 9.7
626 noonan syndrome 1 9.7
627 prostate cancer 9.7
628 retinal detachment 9.7
629 schistosoma mansoni infection, susceptibility/ 9.7
630 thrombocytopenia 2 9.7
631 down syndrome 9.7
632 suppressor of tumorigenicity 3 9.7
633 lung cancer 9.7
634 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.7
635 enterocolitis 9.7
636 hydrops fetalis, nonimmune 9.7
637 lambert syndrome 9.7
638 myelofibrosis 9.7
639 3-methylglutaconic aciduria, type iii 9.7
640 periodontitis, chronic 9.7
641 retinitis pigmentosa 9.7
642 rheumatic fever-related antigen 9.7
643 asplenia, isolated congenital 9.7
644 thrombocytopenia 3 9.7
645 body mass index quantitative trait locus 11 9.7
646 fragile x syndrome 9.7
647 agammaglobulinemia, x-linked 9.7
648 retinitis pigmentosa 11 9.7
649 pituitary adenoma, prolactin-secreting 9.7
650 cd4/cd8 t-cell ratio 9.7
651 body mass index quantitative trait locus 9 9.7
652 macular degeneration, age-related, 1 9.7
653 homocysteinemia 9.7
654 body mass index quantitative trait locus 8 9.7
655 meningioma, radiation-induced 9.7
656 body mass index quantitative trait locus 1 9.7
657 meningioma, familial 9.7
658 body mass index quantitative trait locus 4 9.7
659 frontotemporal lobar degeneration with tdp43 inclusions, grn-related 9.7
660 body mass index quantitative trait locus 10 9.7
661 mycobacterium tuberculosis 1 9.7
662 body mass index quantitative trait locus 7 9.7
663 myocardial infarction 9.7
664 severe cutaneous adverse reaction 9.7
665 celiac disease 3 9.7
666 systemic lupus erythematosus 5 9.7
667 systemic lupus erythematosus 8 9.7
668 systemic lupus erythematosus 11 9.7
669 systemic lupus erythematosus 12 9.7
670 body mass index quantitative trait locus 12 9.7
671 acute promyelocytic leukemia 9.7
672 body mass index quantitative trait locus 14 9.7
673 microvascular complications of diabetes 3 9.7
674 microvascular complications of diabetes 4 9.7
675 microvascular complications of diabetes 6 9.7
676 microvascular complications of diabetes 7 9.7
677 premature ovarian failure 7 9.7
678 multiple sclerosis 5 9.7
679 body mass index quantitative trait locus 18 9.7
680 autoimmune lymphoproliferative syndrome, type v 9.7
681 body mass index quantitative trait locus 19 9.7
682 body mass index quantitative trait locus 20 9.7
683 chlamydia pneumonia 9.7
684 bacterial sepsis 9.7
685 multinodular goiter 9.7
686 small cell carcinoma 9.7
687 peripheral t-cell lymphoma 9.7
688 primary progressive multiple sclerosis 9.7
689 hemorrhagic cystitis 9.7
690 ptosis 9.7
691 x-linked chondrodysplasia punctata 1 9.7
692 penicillin allergy 9.7
693 chronic myelomonocytic leukemia 9.7
694 hyper ige syndrome 9.7
695 familial cold autoinflammatory syndrome 9.7
696 angioimmunoblastic t-cell lymphoma 9.7
697 osteomyelitis 9.7
698 mumps 9.7
699 mooren's ulcer 9.7
700 renal hypertension 9.7
701 premature menopause 9.7
702 hydrocephalus 9.7
703 plummer's disease 9.7
704 erysipelas 9.7
705 spinal meningioma 9.7
706 pulmonary edema 9.7
707 gestational diabetes 9.7
708 esophagitis 9.7
709 otosclerosis 9.7
710 posterior uveitis 9.7
711 leiomyoma 9.7
712 cardiovascular system disease 9.7
713 nontoxic goiter 9.7
714 hyperparathyroidism 9.7
715 biliary atresia 9.7
716 schistosomiasis 9.7
717 46 xx gonadal dysgenesis 9.7
718 panniculitis 9.7
719 keratosis 9.7
720 pneumothorax 9.7
721 mononeuritis multiplex 9.7
722 ectodermal dysplasia 9.7
723 dental caries 9.7
724 thrombocytosis 9.7
725 pharyngitis 9.7
726 motor neuron disease 9.7
727 gastroenteritis 9.7
728 sensory peripheral neuropathy 9.7
729 contact dermatitis 9.7
730 nonspecific interstitial pneumonia 9.7
731 adenocarcinoma 9.7
732 gingivitis 9.7
733 ischemia 9.7
734 central nervous system disease 9.7
735 plasmacytoma 9.7
736 insulinoma 9.7
737 heart valve disease 9.7
738 hypertrichosis 9.7
739 pyoderma 9.7
740 peanut allergy 9.7
741 hypokalemia 9.7
742 secretory meningioma 9.7
743 lymphoplasmacyte-rich meningioma 9.7
744 endophthalmitis 9.7
745 calciphylaxis 9.7
746 rapidly progressive glomerulonephritis 9.7
747 poliomyelitis 9.7
748 human immunodeficiency virus infectious disease 9.7
749 plasma cell neoplasm 9.7
750 cocaine abuse 9.7
751 osteoarthritis 9.7
752 pyoderma gangrenosum 9.7
753 chorioretinitis 9.7
754 learning disability 9.7
755 visceral leishmaniasis 9.7
756 viral infectious disease 9.7
757 diabetes insipidus 9.7
758 blepharitis 9.7
759 fatty liver disease 9.7
760 postpartum depression 9.7
761 bronchiectasis 9.7
762 interstitial keratitis 9.7
763 muscular dystrophy 9.7
764 toxoplasmosis 9.7
765 eosinophilia-myalgia syndrome 9.7
766 albinism 9.7
767 ankrd26-related thrombocytopenia 9.7
768 sickle cell disease 9.7
769 48,xyyy 9.7
770 angioimmunoblastic lymphadenopathy with dysproteinemia 9.7
771 banti's syndrome 9.7
772 catastrophic antiphospholipid syndrome 9.7
773 diffuse cutaneous systemic sclerosis 9.7
774 giant cell myocarditis 9.7
775 haemophilus influenzae 9.7
776 hypomelanotic disorder 9.7
777 kikuchi disease 9.7
778 linear iga disease 9.7
779 lymphocytic hypophysitis 9.7
780 lymphosarcoma 9.7
781 pediatric ulcerative colitis 9.7
782 pseudo-turner syndrome 9.7
783 spondylarthropathy 9.7
784 sudden sensorineural hearing loss 9.7
785 wells syndrome 9.7
786 hypoxia 9.7
787 spinal cord injury 9.7
788 syncope 9.7
789 acute transverse myelitis 9.7
790 immune complex mediated vasculitis 9.7
791 secondary hemophagocytic lymphohistiocytosis 9.7
792 idiopathic nephrotic syndrome 9.7
793 secondary vasculitis 9.7
794 erythema multiforme major 9.7
795 familial chilblain lupus 9.7
796 igg4-related thyroid disease 9.7
797 argyria 9.7
798 autoimmune hepatitis type 2 9.7
799 acute liver failure 9.7
800 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.7
801 glomerular disease 9.7
802 type ii mixed cryoglobulinemia 9.7
803 refractory anemia 9.7
804 angioedema, hereditary, type i 9.5
805 gastroesophageal reflux 9.5
806 b-cell growth factor 9.5
807 aortic valve disease 1 9.5
808 bladder cancer 9.5
809 breast cancer 9.5
810 cardiac arrhythmia 9.5
811 cardiac conduction defect 9.5
812 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.5
813 familial cold autoinflammatory syndrome 1 9.5
814 creutzfeldt-jakob disease 9.5
815 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 9.5
816 diabetes mellitus, noninsulin-dependent 9.5
817 erythermalgia, primary 9.5
818 fibrosis of extraocular muscles, congenital, 1 9.5
819 gilles de la tourette syndrome 9.5
820 hemifacial atrophy, progressive 9.5
821 huntington disease 9.5
822 hyperimmunoglobulin g1 syndrome 9.5
823 macroglobulinemia, waldenstrom 1 9.5
824 meniere disease 9.5
825 moebius syndrome 9.5
826 myelopathy, htlv-1-associated 9.5
827 ovarian cancer 9.5
828 piebald trait 9.5
829 pelvic organ prolapse 9.5
830 retinitis pigmentosa 10 9.5
831 keratosis, seborrheic 9.5
832 blau syndrome 9.5
833 telangiectasia, hereditary benign 9.5
834 thyroid cancer, nonmedullary, 1 9.5
835 muckle-wells syndrome 9.5
836 vasculopathy, retinal, with cerebral leukodystrophy 9.5
837 williams-beuren syndrome 9.5
838 zinc finger protein 1 9.5
839 lipoid congenital adrenal hyperplasia 9.5
840 ataxia-telangiectasia 9.5
841 chondrosarcoma 9.5
842 cryptorchidism, unilateral or bilateral 9.5
843 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 9.5
844 wolfram syndrome 1 9.5
845 neuropathy, hereditary sensory and autonomic, type iii 9.5
846 endocardial fibroelastosis 9.5
847 factor v deficiency 9.5
848 hemochromatosis, neonatal 9.5
849 hemochromatosis, type 1 9.5
850 hutterite cerebroosteonephrodysplasia syndrome 9.5
851 hypogonadism, male 9.5
852 kuru 9.5
853 lymphoid interstitial pneumonia 9.5
854 mycosis fungoides 9.5
855 ocular motor apraxia 9.5
856 pancreatic cancer 9.5
857 subacute sclerosing panencephalitis 9.5
858 hyper-igd syndrome 9.5
859 pituitary hormone deficiency, combined, 2 9.5
860 scott syndrome 9.5
861 polycythemia vera 9.5
862 inflammatory bowel disease 1 9.5
863 hemophagocytic lymphohistiocytosis, familial, 1 9.5
864 autoimmune polyendocrine syndrome, type ii 9.5
865 secretory component deficiency 9.5
866 insulin-like growth factor i 9.5
867 hypomelanosis of ito 9.5
868 severe combined immunodeficiency, x-linked 9.5
869 aland island eye disease 9.5
870 rett syndrome 9.5
871 cyclic vomiting syndrome 9.5
872 gallbladder disease 1 9.5
873 hyperferritinemia with or without cataract 9.5
874 deafness, autosomal dominant 6 9.5
875 supranuclear palsy, progressive, 1 9.5
876 diabetes mellitus, insulin-dependent, 12 9.5
877 diabetes mellitus, insulin-dependent, 6 9.5
878 malignant atrophic papulosis 9.5
879 psoriasis 2 9.5
880 omenn syndrome 9.5
881 brittle bone disorder 9.5
882 sickle cell anemia 9.5
883 rheumatoid arthritis, systemic juvenile 9.5
884 inflammatory bowel disease 3 9.5
885 orthostatic intolerance 9.5
886 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.5
887 systemic lupus erythematosus 2 9.5
888 dianzani autoimmune lymphoproliferative disease 9.5
889 immunodeficiency with hyper-igm, type 2 9.5
890 psoriasis 6 9.5
891 neurodegeneration with brain iron accumulation 3 9.5
892 pars planitis 9.5
893 aortic aneurysm, familial thoracic 1 9.5
894 nasopharyngeal carcinoma 9.5
895 anxiety 9.5
896 systemic lupus erythematosus with nephritis 3 9.5
897 neutrophilic dermatosis, acute febrile 9.5
898 endometrial cancer 9.5
899 lung cancer susceptibility 1 9.5
900 systemic lupus erythematosus 7 9.5
901 esophagitis, eosinophilic, 1 9.5
902 systemic lupus erythematosus 9 9.5
903 malaria 9.5
904 asthma-related traits 6 9.5
905 intraocular pressure quantitative trait locus 9.5
906 lipoprotein glomerulopathy 9.5
907 thrombocytopenia 4 9.5
908 ewing sarcoma 9.5
909 diabetes mellitus, ketosis-prone 9.5
910 systemic lupus erythematosus 10 9.5
911 inflammatory bowel disease 16 9.5
912 myd88 deficiency 9.5
913 systemic lupus erythematosus 13 9.5
914 psoriasis 10 9.5
915 microvascular complications of diabetes 5 9.5
916 leukemia, acute lymphoblastic 9.5
917 fatty liver disease, nonalcoholic 1 9.5
918 complement component c1s deficiency 9.5
919 aspergillosis 9.5
920 systemic lupus erythematosus 16 9.5
921 ras-associated autoimmune leukoproliferative disorder 9.5
922 peripartum cardiomyopathy 9.5
923 immunodeficiency, common variable, 8, with autoimmunity 9.5
924 cfhr5 deficiency 9.5
925 human herpesvirus 8 9.5
926 leptin deficiency or dysfunction 9.5
927 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.5
928 alacrima, achalasia, and mental retardation syndrome 9.5
929 glucocorticoid resistance, generalized 9.5
930 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.5
931 mulchandani-bhoj-conlin syndrome 9.5
932 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.5
933 angina pectoris 9.5
934 drug-induced lupus erythematosus 9.5
935 secretory diarrhea 9.5
936 aspiration pneumonia 9.5
937 cryptogenic organizing pneumonia 9.5
938 tick-borne encephalitis 9.5
939 hypophosphatemia 9.5
940 arrhythmogenic right ventricular cardiomyopathy 9.5
941 epidemic typhus 9.5
942 variola major 9.5
943 adult t-cell leukemia 9.5
944 brachydactyly 9.5
945 chorioamnionitis 9.5
946 anaplastic large cell lymphoma 9.5
947 mantle cell lymphoma 9.5
948 lymphoplasmacytic lymphoma 9.5
949 metabolic acidosis 9.5
950 first-degree atrioventricular block 9.5
951 peripheral artery disease 9.5
952 infective endocarditis 9.5
953 c1 inhibitor deficiency 9.5
954 cd40 ligand deficiency 9.5
955 pervasive developmental disorder 9.5
956 sexual disorder 9.5
957 alexithymia 9.5
958 diffuse alopecia areata 9.5
959 microscopic colitis 9.5
960 atrial fibrillation 9.5
961 stuttering 9.5
962 paroxysmal nocturnal hemoglobinuria 9.5
963 inguinal hernia 9.5
964 drug allergy 9.5
965 griscelli syndrome 9.5
966 intestinal pseudo-obstruction 9.5
967 polycystic kidney disease 9.5
968 non-alcoholic steatohepatitis 9.5
969 coronavirus infectious disease 9.5
970 middle east respiratory syndrome 9.5
971 rasopathy 9.5
972 type 1 diabetes mellitus 2 9.5
973 type 1 diabetes mellitus 3 9.5
974 castleman disease 9.5
975 migraine with aura 9.5
976 corneal disease 9.5
977 venous insufficiency 9.5
978 optic papillitis 9.5
979 thalassemia 9.5
980 pneumoconiosis 9.5
981 asbestosis 9.5
982 anthracosis 9.5
983 siderosis 9.5
984 chronic leukemia 9.5
985 nasopharyngitis 9.5
986 esophageal atresia 9.5
987 orbital granuloma 9.5
988 gastric lymphoma 9.5
989 osteomalacia 9.5
990 leukodystrophy 9.5
991 glucose intolerance 9.5
992 lactose intolerance 9.5
993 protein-losing enteropathy 9.5
994 wolfram syndrome 9.5
995 gastric ulcer 9.5
996 lepromatous leprosy 9.5
997 amnestic disorder 9.5
998 gastrojejunal ulcer 9.5
999 hemiplegia 9.5
1000 alport syndrome 9.5
1001 discitis 9.5
1002 q fever 9.5
1003 bartonellosis 9.5
1004 hydronephrosis 9.5
1005 sarcoma 9.5
1006 anhidrosis 9.5
1007 primary hyperparathyroidism 9.5
1008 disseminated intravascular coagulation 9.5
1009 microcytic anemia 9.5
1010 rabies 9.5
1011 keratomalacia 9.5
1012 choroiditis 9.5
1013 retinal vasculitis 9.5
1014 listeria meningitis 9.5
1015 listeriosis 9.5
1016 cauda equina syndrome 9.5
1017 hyperandrogenism 9.5
1018 onchocerciasis 9.5
1019 dysgammaglobulinemia 9.5
1020 neonatal diabetes mellitus 9.5
1021 lyme disease 9.5
1022 iron deficiency anemia 9.5
1023 protein-energy malnutrition 9.5
1024 visual epilepsy 9.5
1025 coronary thrombosis 9.5
1026 mononeuropathy 9.5
1027 hypertrophic cardiomyopathy 9.5
1028 panuveitis 9.5
1029 hemosiderosis 9.5
1030 tympanosclerosis 9.5
1031 tinea corporis 9.5
1032 bile reflux 9.5
1033 male infertility 9.5
1034 shigellosis 9.5
1035 tinea pedis 9.5
1036 bell's palsy 9.5
1037 von willebrand's disease 9.5
1038 acoustic neuroma 9.5
1039 intermediate uveitis 9.5
1040 thyroid crisis 9.5
1041 hypochondriasis 9.5
1042 shipyard eye 9.5
1043 paronychia 9.5
1044 focal segmental glomerulosclerosis 9.5
1045 severe pre-eclampsia 9.5
1046 hellp syndrome 9.5
1047 megaesophagus 9.5
1048 brain cancer 9.5
1049 endemic goiter 9.5
1050 mycoplasma pneumoniae pneumonia 9.5
1051 scrub typhus 9.5
1052 cardiac sarcoidosis 9.5
1053 tuberous sclerosis 9.5
1054 obstructive jaundice 9.5
1055 sapho syndrome 9.5
1056 iritis 9.5
1057 blackwater fever 9.5
1058 selective igg deficiency disease 9.5
1059 adult dermatomyositis 9.5
1060 oral candidiasis 9.5
1061 suppurative cholangitis 9.5
1062 acute cholangitis 9.5
1063 pleuropneumonia 9.5
1064 pyuria 9.5
1065 pleural disease 9.5
1066 arthus reaction 9.5
1067 fungal infectious disease 9.5
1068 limited scleroderma 9.5
1069 lymphadenitis 9.5
1070 neuroendocrine tumor 9.5
1071 duodenal ulcer 9.5
1072 facial hemiatrophy 9.5
1073 cerebral palsy 9.5
1074 neuroma 9.5
1075 hyperinsulinism 9.5
1076 hyperostosis 9.5
1077 intestinal perforation 9.5
1078 essential thrombocythemia 9.5
1079 myeloproliferative neoplasm 9.5
1080 prothrombin deficiency 9.5
1081 spondylosis 9.5
1082 hidradenitis suppurativa 9.5
1083 hidradenitis 9.5
1084 keratopathy 9.5
1085 nocardiosis 9.5
1086 colon adenocarcinoma 9.5
1087 retinal vascular disease 9.5
1088 testicular disease 9.5
1089 hemangioma 9.5
1090 rhizomelic chondrodysplasia punctata 9.5
1091 larynx cancer 9.5
1092 auditory system disease 9.5
1093 hairy cell leukemia 9.5
1094 newcastle disease 9.5
1095 pulmonary tuberculosis 9.5
1096 testicular cancer 9.5
1097 substance abuse 9.5
1098 allergic contact dermatitis 9.5
1099 astrocytoma 9.5
1100 gallbladder cancer 9.5
1101 scleredema adultorum 9.5
1102 mucinoses 9.5
1103 tropical spastic paraparesis 9.5
1104 lysosomal storage disease 9.5
1105 complex regional pain syndrome 9.5
1106 central nervous system lymphoma 9.5
1107 aspiration pneumonitis 9.5
1108 rhabdomyosarcoma 9.5
1109 thymic carcinoma 9.5
1110 breast adenocarcinoma 9.5
1111 breast disease 9.5
1112 plague 9.5
1113 necrobiosis lipoidica 9.5
1114 signet ring cell adenocarcinoma 9.5
1115 chronic wasting disease 9.5
1116 gastric adenocarcinoma 9.5
1117 granuloma annulare 9.5
1118 anovulation 9.5
1119 pleural empyema 9.5
1120 porokeratosis 9.5
1121 pituitary adenoma 9.5
1122 thrombophlebitis 9.5
1123 placental insufficiency 9.5
1124 merkel cell carcinoma 9.5
1125 eosinophilic gastroenteritis 9.5
1126 lymphocytic gastritis 9.5
1127 tricuspid valve insufficiency 9.5
1128 spindle cell sarcoma 9.5
1129 coronary restenosis 9.5
1130 coronary stenosis 9.5
1131 conjunctivochalasis 9.5
1132 polyradiculopathy 9.5
1133 egg allergy 9.5
1134 granulomatous dermatitis 9.5
1135 pleomorphic adenoma 9.5
1136 bile duct cancer 9.5
1137 ulnar neuropathy 9.5
1138 gastric neuroendocrine neoplasm 9.5
1139 somatoform disorder 9.5
1140 anti-basement membrane glomerulonephritis 9.5
1141 epidermolysis bullosa dystrophica 9.5
1142 adjustment disorder 9.5
1143 borna disease 9.5
1144 arteriosclerosis obliterans 9.5
1145 von economo's disease 9.5
1146 central nervous system vasculitis 9.5
1147 blepharospasm 9.5
1148 intestinal disease 9.5
1149 pituitary gland disease 9.5
1150 gingival hypertrophy 9.5
1151 colonic disease 9.5
1152 functioning pituitary adenoma 9.5
1153 scrapie 9.5
1154 mediastinal cancer 9.5
1155 kidney disease 9.5
1156 lymphoepithelioma-like carcinoma 9.5
1157 retinal disease 9.5
1158 adenosine deaminase deficiency 9.5
1159 hemoglobinuria 9.5
1160 pediatric lymphoma 9.5
1161 nephrolithiasis 9.5
1162 paraplegia 9.5
1163 bronchitis 9.5
1164 hypersplenism 9.5
1165 viral encephalitis 9.5
1166 prion disease 9.5
1167 compartment syndrome 9.5
1168 inverted follicular keratosis 9.5
1169 placenta disease 9.5
1170 scabies 9.5
1171 appendicitis 9.5
1172 extrinsic allergic alveolitis 9.5
1173 polycythemia 9.5
1174 pellagra 9.5
1175 influenza 9.5
1176 mucormycosis 9.5
1177 rheumatoid arthritis interstitial lung disease 9.5
1178 impetigo 9.5
1179 monocytic leukemia 9.5
1180 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.5
1181 duodenitis 9.5
1182 neurofibromatosis 9.5
1183 vascular dementia 9.5
1184 smallpox 9.5
1185 bacterial pneumonia 9.5
1186 intermediate coronary syndrome 9.5
1187 parasitic helminthiasis infectious disease 9.5
1188 dermatophytosis 9.5
1189 skin melanoma 9.5
1190 cowpox 9.5
1191 autosomal dominant polycystic kidney disease 9.5
1192 peroxisomal disease 9.5
1193 rem sleep behavior disorder 9.5
1194 cutaneous leishmaniasis 9.5
1195 dyskinesia of esophagus 9.5
1196 amino acid metabolic disorder 9.5
1197 chronic cholangitis 9.5
1198 non-secretory myeloma 9.5
1199 aphthous stomatitis 9.5
1200 yellow fever 9.5
1201 diabetic neuropathy 9.5
1202 refractive error 9.5
1203 periostitis 9.5
1204 keloid disorder 9.5
1205 myotonic dystrophy 9.5
1206 c3 glomerulopathy 9.5
1207 hereditary distal renal tubular acidosis 9.5
1208 acute zonal occult outer retinopathy 9.5
1209 alopecia totalis 9.5
1210 amyloidosis aa 9.5
1211 anti-pit-1 antibody syndrome 9.5
1212 autoimmune autonomic ganglionopathy 9.5
1213 autoimmune inner ear disease 9.5
1214 basaloid follicular hamartoma 9.5
1215 biliary tract cancer 9.5
1216 central serous chorioretinopathy 9.5
1217 cerebellar degeneration 9.5
1218 cold urticaria 9.5
1219 complement component deficiency 9.5
1220 dense deposit disease 9.5
1221 diabetic mastopathy 9.5
1222 encephalocele 9.5
1223 engraftment syndrome 9.5
1224 erosive pustular dermatosis of the scalp 9.5
1225 erythrokeratoderma ''en cocardes'' 9.5
1226 exfoliative dermatitis 9.5
1227 frontal fibrosing alopecia 9.5
1228 gigantomastia 9.5
1229 granulocytopenia 9.5
1230 growth hormone deficiency 9.5
1231 guttate psoriasis 9.5
1232 halo nevus 9.5
1233 htlv-1 associated myelopathy/tropical spastic paraparesis 9.5
1234 hypocomplementemic urticarial vasculitis 9.5
1235 immunoglobulin g deficiency 9.5
1236 laryngeal papillomatosis 9.5
1237 lichen planus pemphigoides 9.5
1238 linear scleroderma 9.5
1239 lymphomatoid granulomatosis 9.5
1240 macrophagic myofasciitis 9.5
1241 myalgic encephalomyelitis/chronic fatigue syndrome 9.5
1242 myelodysplastic syndrome with excess blasts 9.5
1243 neisseria meningitidis infection 9.5
1244 opsoclonus-myoclonus syndrome 9.5
1245 parainfluenza virus type 3 9.5
1246 paraneoplastic cerebellar degeneration 9.5
1247 pediatric autoimmune neuropsychiatric disorders associated with streptococcus infections 9.5
1248 pediatric multiple sclerosis 9.5
1249 pleuroparenchymal fibroelastosis 9.5
1250 post-transplant lymphoproliferative disease 9.5
1251 primary agammaglobulinemia 9.5
1252 primary angiitis of the central nervous system 9.5
1253 primary central nervous system lymphoma 9.5
1254 prosthetic joint infection 9.5
1255 pseudobulbar affect 9.5
1256 pustular psoriasis 9.5
1257 pustulosis palmaris et plantaris 9.5
1258 retroperitoneal fibrosis 9.5
1259 rheumatoid vasculitis 9.5
1260 rosai-dorfman disease 9.5
1261 spastic paraparesis 9.5
1262 streptococcal group a invasive disease 9.5
1263 susac syndrome 9.5
1264 thrombotic thrombocytopenic purpura, acquired 9.5
1265 wallerian degeneration 9.5
1266 warm antibody hemolytic anemia 9.5
1267 cryptogenic cirrhosis 9.5
1268 back pain 9.5
1269 brain injury 9.5
1270 cerebral aneurysms 9.5
1271 hypotonia 9.5
1272 myotonia 9.5
1273 paraneoplastic syndromes 9.5
1274 seizure disorder 9.5
1275 spasticity 9.5
1276 traumatic brain injury 9.5
1277 posttransplant acute limbic encephalitis 9.5
1278 chronic cutaneous lupus erythematosus 9.5
1279 idiopathic bilateral vestibulopathy 9.5
1280 asbestos intoxication 9.5
1281 differentiated thyroid carcinoma 9.5
1282 autoimmune pancreatitis type 1 9.5
1283 progressive muscular dystrophy 9.5
1284 rare hereditary hemochromatosis 9.5
1285 primary anetoderma 9.5
1286 infundibulo-neurohypophysitis 9.5
1287 igg4-related mesenteritis 9.5
1288 chronic enteropathy associated with slco2a1 gene 9.5
1289 refractory celiac disease 9.5
1290 osteonecrosis of the jaw 9.5
1291 neonatal scleroderma 9.5
1292 secondary pulmonary alveolar proteinosis 9.5
1293 rare sleep disorder 9.5
1294 complications after hematopoietic stem cell transplantation 9.5
1295 methotrexate-associated lymphoproliferative disorders 9.5
1296 autosomal dominant non-syndromic sensorineural deafness type dfna 9.5
1297 non-functioning pituitary adenoma 9.5
1298 premature aging 9.5
1299 hyperpigmentation of the skin 9.5
1300 pemphigus vegetans 9.5
1301 large granular lymphocyte leukemia 9.5
1302 refractory cytopenia with multilineage dysplasia 9.5
1303 primary hypophysitis 9.5
1304 adenohypophysitis 9.5
1305 panhypophysitis 9.5
1306 pediatric systemic lupus erythematosus 9.5
1307 thrombotic microangiopathy 9.5
1308 overgrowth syndrome 9.5
1309 rare coagulation disorder 9.5
1310 thyroid tumor 9.5
1311 precursor t-cell acute lymphoblastic leukemia 9.5

Graphical network of the top 20 diseases related to Autoimmune Disease 1:



Diseases related to Autoimmune Disease 1

Symptoms & Phenotypes for Autoimmune Disease 1

Human phenotypes related to Autoimmune Disease 1:

31 (showing 2, show less)
# Description HPO Frequency HPO Source Accession
1 hashimoto thyroiditis 31 HP:0000872
2 vitiligo 31 HP:0001045

Symptoms via clinical synopsis from OMIM:

56
Skin Nails Hair Skin:
vitiligo, generalized
depigmentation, slowly progressive and diffuse

Endocrine Features:
hashimoto thyroiditis (some patients)

Clinical features from OMIM:

607836

Drugs & Therapeutics for Autoimmune Disease 1

Drugs for Autoimmune Disease 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 487, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ledipasvir Approved Phase 4 1256388-51-8 67505836
2
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
3
Simvastatin Approved Phase 4 79902-63-9 54454
4
Dimethyl fumarate Approved, Investigational Phase 4 624-49-7 5271565 637568
5
Azithromycin Approved Phase 4 83905-01-5 447043 55185
6
Angiotensin II Approved, Investigational Phase 4 4474-91-3, 11128-99-7, 68521-88-0 172198
7
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
8
Azathioprine Approved Phase 4 446-86-6 2265
9
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
10
Zinc Approved, Investigational Phase 4 7440-66-6 32051
11
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
12
Insulin aspart Approved Phase 4 116094-23-6 16132418
13
Insulin glargine Approved Phase 4 160337-95-1
14
Entecavir Approved, Investigational Phase 4 142217-69-4 153941
15 Strawberry Approved Phase 4
16 Orange Approved Phase 4
17 Artichoke Approved Phase 4
18
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
19
Adalimumab Approved Phase 4 331731-18-1 16219006
20
Methotrexate Approved Phase 4 59-05-2, 1959-05-2 126941
21
Infliximab Approved Phase 4 170277-31-3
22
Etanercept Approved, Investigational Phase 4 185243-69-0
23
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
24
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
25
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
26 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
27
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
28
Artesunate Approved, Investigational Phase 4 88495-63-0 6917864 5464098
29
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
30
Hydroxychloroquine Approved Phase 4 118-42-3 3652
31
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
32
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
33
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
34
Povidone Approved Phase 4 9003-39-8
35
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
36
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 5280453 134070
37
Melatonin Approved, Nutraceutical, Vet_approved Phase 4 73-31-4 896
38
Tenofovir Experimental, Investigational Phase 4 147127-20-6 464205
39
Adefovir Investigational Phase 4 106941-25-7
40
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
41 Rosuvastatin Calcium Phase 4 147098-20-2
42 Hypolipidemic Agents Phase 4
43 Lipid Regulating Agents Phase 4
44 Anticholesteremic Agents Phase 4
45 Vasoconstrictor Agents Phase 4
46 Angiotensin II Type 1 Receptor Blockers Phase 4
47 Angiotensinogen Phase 4
48 Angiotensin Receptor Antagonists Phase 4
49 Giapreza Phase 4
50 interferons Phase 4
51 Omega 3 Fatty Acid Phase 4
52 Interferon-alpha Phase 4
53 Antiviral Agents Phase 4
54 Interferon alpha-2 Phase 4
55 Anti-HIV Agents Phase 4
56 Anti-Retroviral Agents Phase 4
57 Protective Agents Phase 4
58 Estrogens Phase 4
59 Reverse Transcriptase Inhibitors Phase 4
60 Dihydroxycholecalciferols Phase 4
61 Insulin degludec, insulin aspart drug combination Phase 4
62 Insulin, Long-Acting Phase 4
63 Olive Phase 4
64 Estrogens, Conjugated (USP) Phase 4
65 Analgesics Phase 4
66 Folic Acid Antagonists Phase 4
67 Analgesics, Non-Narcotic Phase 4
68 Liver Extracts Phase 4
69 Complement System Proteins Phase 4
70 Complement C3 Phase 4
71 Methylprednisolone Acetate Phase 4
72 Anthelmintics Phase 4
73 Neuroprotective Agents Phase 4
74 Antioxidants Phase 4
75 silymarin Phase 4
76 Tin Fluorides Phase 4
77 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
78 Progestins Phase 4
79 Lactoferrin Phase 4
80 Antiparasitic Agents Phase 4
81 Antiprotozoal Agents Phase 4
82